2017 South Korean pharmaceutical exports exceeded US$4 billion

Medical Network September 26th According to a data released by the Korea Food and Drug Safety Service on the 6th, the export of Korean pharmaceutical products exceeded US$4 billion in 2017, a record high.

Data show that last year Korean doctor drug Exports increased by 30.5% year-on-year to reach US$4,011.2 billion. Among them, medicine The export value of products increased by 28.6% year-on-year, reaching USD 138.851 million, accounting for 33.6% of the total export of pharmaceutical products.

In the case of the continued trade deficit in the Korean pharmaceutical industry, only the export of biopharmaceuticals has improved. Last year, the trade balance reached a surplus of 368.7 billion won. The trade balance of biopharmaceutical products has achieved a surplus for three consecutive years, and its scale. Compared with 2016, it increased by 108.3%.

In the same period, Korea's pharmaceutical production was 20.358 trillion won (approximately RMB 1.243 billion), an increase of 8.3% year-on-year, surpassing the 20 trillion won mark for the first time. Pharmaceutical production accounted for Korea's gross domestic product (GDP). The proportion is 1.18%.

The relevant person in charge of the Food Safety Department said that the continuous increase in the production and export of pharmaceutical products in Korea is due to the unremitting efforts of the pharmaceutical industry and the government's technical and policy support. In order to improve the competitiveness of the Korean pharmaceutical industry, the government will continue to work hard.